Femara ingredients
Femara contains "letrozole", which helps increase estrogen levels by inhibiting the enzyme "aromatase", which reduces the synthesis of strogen, helping to treat estrogen-dependent breast cancer.
Femara uses
Femara 2.5 mg tablets are used for the treatment of estrogen-dependent breast cancer in the blood as follows:
-
Adjuvant treatment for early hormone +ve breast cancer postmenopausal.
-
extended adjuvant treatment for women with early breast cancer after menopause who have previously received tamoxifen for 5 years.
-
A first-line treatment for advanced breast cancer which is hormone dependent.
-
Treatment of advanced breast cancer relapse or progression of the disease for women who have artificially induced postmenopausal state, who have previously been treated by anti-estrogens.
-
Dosage of Vimara tablets
-
The appropriate dose of Vimara's tablets is determined by the doctor.
-
The recommended dose per day is a tablet of 2.5 mg once per day.
Femara Side Effects
Femara may cause some side effects, such as:
-
Hypercholesterolemia.
-
Increase or low appetite.
-
Depression.
-
headache.
-
dizziness.
-
palpitations.
-
Hot flushes.
-
High blood pressure.
-
Nausea and vomiting.
-
excessive sweating.
-
Joint pain.
-
vaginal bleeding.
-
Weight gain.
Femara contraindications
Femara is not used in the case of:
-
Allergy to drug ingredients.
-
Pregnancy and lactation.
Femara use precautions
The doctor should be consulted before using the medicine Femara, especially in the case of:
-
osteoporosis, as the risk of developing it may increase.
-
kidney disease.
-
liver disease.
-
Uncleraed menopausal status.
Drug interactions
The doctor should be consulted before taking Femarawith any other medication, especially:
-
Antifungal.
-
Antibiotics.
-
Antiepileptic.
-
Tamoxifen.
-
Anticoagulants.
